Expression, purification, crystallization and preliminary X-ray diffraction analysis of a type II NADH:quinone oxidoreductase from the human pathogen Staphylococcus aureus
In recent years, type II NADH dehydrogenases (NDH‐IIs) have emerged as potential drug targets for a wide range of human disease causative agents. In this work, the NDH‐II enzyme from the Gram‐positive human pathogen Staphylococcus aureus was recombinantly expressed in Escherichia coli, purified, cry...
Saved in:
Published in | Acta crystallographica. Section F, Structural biology communications Vol. 71; no. 4; pp. 477 - 482 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
5 Abbey Square, Chester, Cheshire CH1 2HU, England
International Union of Crystallography
01.04.2015
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In recent years, type II NADH dehydrogenases (NDH‐IIs) have emerged as potential drug targets for a wide range of human disease causative agents. In this work, the NDH‐II enzyme from the Gram‐positive human pathogen Staphylococcus aureus was recombinantly expressed in Escherichia coli, purified, crystallized and a crystallographic data set was collected at a wavelength of 0.873 Å. The crystals belonged to the orthorhombic space group P212121, with unit‐cell parameters a = 81.8, b = 86.0, c = 269.9 Å, contained four monomers per asymmetric unit and diffracted to a resolution of 3.32 Å. A molecular‐replacement solution was obtained and model building and refinement are currently under way. |
---|---|
Bibliography: | istex:AE8C6CC20AB0EC7D31C2A404B1A396A4DD7CEE55 ark:/67375/WNG-Q10LML4G-R ArticleID:AYF2WD5245 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Both authors contributed equally to this work. |
ISSN: | 2053-230X 2053-230X |
DOI: | 10.1107/S2053230X15005178 |